Is rapid testing profitable for pharmacies? With increasing demand for COVID-19 and flu testing, offering point-of-care diagnostics is a significant opportunity for pharmacies to generate revenue and improve patient care. Discover why now is the time to invest in rapid testing.
In recent months, Norovirus, a highly contagious virus, has been identified as spreading at an unexpectedly high frequency across Canada, particularly hitting hard in provinces like Ontario and Alberta. This surge highlights the need for vigilance and quick response to manage and mitigate outbreaks effectively.
The unexpected rise in Norovirus cases this year underscores the necessity for preparedness. By integrating our rapid Norovirus tests into your healthcare and public health strategies, you can tackle outbreaks swiftly and effectively, minimizing their impact on our communities.
As the Healthcare Industry continually changes, the demand for swift and precise diagnostic testing grows increasingly vital. Fluorescent Immunoassay (FIA) Testing, pivotal in contemporary point-of-care diagnostics, is transforming the delivery of health services, especially in remote and less accessible areas.
In the rapidly evolving landscape of healthcare, pharmacists are constantly seeking innovative
The rise in Group A Strep infections across Canada has brought to
The Canadian healthcare system, admired globally for its universal coverage, faces a
